Monoacylglycerol Lipase Inhibition in Tourette Syndrome: A 12‐Week, Randomized, Controlled Study

Cerebrospinal fluid endocannabinoid levels in Gilles de la Tourette syndrome

(2020) Kirsten R. Müller-Vahl et al.   NEUROPSYCHOPHARMACOLOGY

Single center experience with medical cannabis in Gilles de la Tourette syndrome

(2018) Avner Thaler et al.   PARKINSONISM & RELATED DISORDERS

Preliminary Evidence on Cannabis Effectiveness and Tolerability for Adults With Tourette Syndrome

(2017) Elia Abi-Jaoude et al.   JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES

Tics and Touretteʼs

(2016) Christos Ganos   CURRENT OPINION IN NEUROLOGY

The premonitory urge revisited: An individualized premonitory urge for tics scale

(2016) Joseph F. McGuire et al.   JOURNAL OF PSYCHIATRIC RESEARCH

The Role of Atypical Antipsychotics for Treatment of Tourette’s Syndrome: An Overview

(2014) Cathy L. Budman   DRUGS

Detecting a clinically meaningful change in tic severity in Tourette syndrome: A comparison of three methods

(2013) Sangchoon Jeon et al.   Contemporary Clinical Trials

Impact of placebo assignment in clinical trials of tic disorders

(2013) Esther Cubo et al.   MOVEMENT DISORDERS

A multicenter randomized placebo-controlled clinical trial of pramipexole for Tourette's syndrome

(2012) Roger Kurlan et al.   MOVEMENT DISORDERS

Endocannabinoid Modulation of Dopaminergic Motor Circuits

(2012) Teresa Morera-Herreras et al.   Frontiers in Pharmacology

The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults

(2011) Kelly Posner et al.   AMERICAN JOURNAL OF PSYCHIATRY

Defining Treatment Response in Pediatric Tic Disorders: A Signal Detection Analysis of the Yale Global Tic Severity Scale

(2011) Eric A. Storch et al.   JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY

The Gilles de la Tourette Syndrome-Quality of Life Scale (GTS-QOL): Development and validation

(2008) A. E. Cavanna et al.   NEUROLOGY